is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Head of Product Management Drug Delivery Systems
Adam Stops is Head of Product Management for Drug Delivery Systems at Stevanato Group, managing auto-injectors, pre-filled variable and fixed-dose pen injectors, large-volume wearable injectors, and inhalers.Boasting a Ph.D. in Mechanical Engineering and an MBA in business management, Adam Stops has broad experience in the design, development, and product management of devices and parenteral products. He has worked with innovative multinational companies leading teams of experts in device research, design, and industrialization throughout his career.
BD Medical - Pharmaceutical Systems
Clinical & Human Factors Manager - Medical Affairs
Alice Maden is a Clinical & Human Factors Manager at BD Medical – Pharmaceutical Systems. She has 15 years of regulatory experience in pharma and container closure system environments. Dr Maden has been with BD since 2007 and is in charge of the Global and Strategic Accounts & Prefillable Syringes Regulatory Affairs team. She is a Doctor of Pharmacy, from Université Joseph Fourier (Grenoble, France) and holds a Double Master’s Degree in Health and Medicinal Product Engineering from IPIL Lyon, and in Business & Management from Emlyon Business School.
Cambridge Pharma/Oval, SMC Ltd
Asmita Khanolkar has a Master’s degree in Materials Science & Engineering from Worcester Polytechnic Institute in Worcester, MA, USA. With over 25 years of manufacturing experience specializing in the Medical Device and Pharmaceutical industry, she has managed various device projects from concept to commercial launch. Her product portfolio includes single-use, wearable and implantable devices, drug-device, device-biologic combination products for drug delivery, biotech, bio therapeutics and pharmaceutical applications. She has held various engineering and management roles in New Product Development, Manufacturing Engineering, Advanced Quality Planning, Operations, Supply Chain and Product Life Cycle Management. Her current responsibilities include a corporate leadership role supporting multiple sites for bringing complete solutions to the customers, working closely within the Oval Medical Technologies, Cambridge Pharma and SMC Ltd. global sites in early technical engagement through commercialization for combination products and pharmaceutical services
Engagement Manager, Thought Leadership
Aurelio creates topical and forward-looking strategic content relevant to pharma executives and publishes articles, blogs and white papers on a regular basis. He is involved in numerous projects related to increasing access to medicine as well as the interface between healthcare and ESG. He is considered a subject matter expert in these areas and speaks at numerous conferences worldwide, presents at board-level meetings and engages with consulting projects.
Business Development Director
Audrey Chardonnet is Global Business Development Director for Prefillable Syringe Components (PFS) at Aptar Pharma’s Injectables division and is responsible for driving the overall strategy for PFS segments. Audrey previously held several positions within the Aptar Pharma sales organization, most recently as Director, Global Strategic Customers, with a particular focus on business development with syringe manufacturers. Audrey graduated with an Engineering Master’s Degree in Chemistry and has over 12 years of experience in the injectables industry.
Device Project Leader
Annie Zavadil holds a BSc and MSc in Biomedical Engineering from Boston University. Annie started her career at Boston Scientific in Preclinical Sciences and Cell Biology. In 2012, she joined Future Health Biobank, setting up a best in class stem cell isolation laboratory.
In 2014, Annie joined the Device and Packaging Development team at Novartis working as Device Project Lead for various projects from Ophthalmic delivery to Cell and Gene to Sustainability initiatives. In 2018, she joined Novel solutions and technologies where she evaluates new technology opportunities for further development with the Novartis drug portfolio.
Terumo Pharmaceutical Solutions (TPS)
Vice President, Strategy & Marketing
Anil Busimi has more than 15 years of experience in the areas of primary packaging, injection devices, drug delivery devices and CDMO for parenteral drugs. He worked in a variety of positions covering topics in areas of Global strategy, Product management, Marketing, Business development, Market intelligence, Supply chain, and innovation. He joined TPS in Oct.2020 and leading the strategy, product management, marketing communication and Market intelligence teams.
He is passionate about solving pharma, biotech customers and end users problems in the areas of primary packaging, drug delivery devices, and fill and finish aspects for injectable drugs.
Charbel Tengroth is an experienced professional having worked in various leader roles within the fields of aseptic drug product and process development, and medical devices and combination products. Charbel has a strong scientific background holding a PhD in physics from Chalmers Institute of Technology and post-graduate research positions at Princeton University and AstraZeneca R&D.
He is now the CEO of Norrneo AB, a medical device innovation and development company that he founded together with Anders Holmqvist.
Before starting his company, Charbel held leader positions in SHL Medical and Pfizer.
Over the years Charbel has contributed to the success of a wide range of pharmaceutical products and medical devices such as Prevnar 13, Genotropin, Depo-Provera/Sayana, and the DAI and Molly families of injection devices.
Head of Front End Innovation
Charlotte is Head of Front End Innovation at Team Consulting. She is an experienced project manager and facilitator, guiding clients through both difficult strategic decisions and encouraging creative thinking through the facilitation of innovation workshops. She has a wealth of experience in contextual/design research and many innovation tools under her belt to help navigate through the fuzzy front end of product development.
Charlotte has a BEng in Integrated Engineering and a MSc in Medical Engineering and Physics. She has worked in the medical devices industry for over 20 years in clinical, research, start-up and consultancy environments.
Haselmeier, a medmix Brand
Vice President of Innovation and Development
Chris Muenzer is the Vice President of Innovation and Development at Haselmeier, a medmix Brand. At Haselmeier he leads a team of experts that create customized drug delivery systems for pharmaceutical and biotechnology companies.
He has over 15 years of experience in the pharmaceutical and medical device industry, having worked at Novartis, Roche, and the Battelle Memorial Institute. During this time he has worked at all stages of device development from initial concept, engineering development, clinical trials, and launch.
Mr. Muenzer holds a BSME from Carnegie Mellon University in Pittsburgh, Pennsylvania in the US. He is also the inventor of several patents and is a frequent contributor to industry conferences and ISO standards.
Helbling Technik Bern AG
Ellen has 20 years’ experience in the waste resources industry. She particularly focusses on collection and onward routes for materials after consumers have used. She has worked on a large number of projects that explore options for product take back including working with a pharmaceutical company to establish take back options for three hard to recycle materials in a number of European markets.
MP Corporate Finance GmbH
West Pharmaceutical Services
Sr. Director, Global Business Development
Gurmeet Singh is a senior director, Business Development at West. In her current role, she manages a global team that collaborates with strategic pharmaceutical companies to sell services and solutions to support the development of combination products to bring optimal drug delivery options for patients, caregivers and providers. These include West proprietary product platforms and third party drug delivery solutions, with services that include design and development through clinical readiness to scale-up and manufacturing.
Gurmeet is an experienced business leader in pharmaceutical packaging, including drug delivery devices, for injectable drugs with a strong focus in combination product development and commercialization projects working with multiple global pharmaceutical partners. She is passionate about bringing innovative solutions that are designed with the patient in mind, with the intent to improve their lives. Gurmeet is knowledgeable and experienced professional supporting all aspects of device development, cGMP manufacturing as well as global regulatory compliance.
Director of Business Development
Gemma Budd is Business Development Director for Nanopharm, an Aptar Company, where she is primarily responsible for developing business and collaborative opportunities for Aptar Pharma’s services, solutions and technologies in the orally inhaled and nasal drug product (OINDP) sector. With a university degree in Biomedical Sciences, Gemma has over 10 years of experience in the pharmaceutical industry in both research and commercial positions, from materials science and analytical services, to formulation technology and drug delivery devices, primarily for oral and inhaled dosage forms.
Chief Enablement Officer (CEO)
Dr. Mahler is Founder, CEO and Board Member at ten23 health AG, the human-centric and sustainable pharmaceutical development partner.
He is also adjunct faculty at the Universities of Frankfurt (Germany) and Basel (Switzerland), serves as Scientifc Expert (Ph.Eur.) at EDQM and as Board Member for Bionter & KriyaBio.
Previously, Dr. Mahler has been leading the Drug Product Services Business Unit at Lonza AG, leading Pharmaceutical Development & Supplies Biologics at Roche (Basel), and as Principal Scientist & CMC Team leader Erbitux at Merck KGaA.
He studied Pharmacy & holds in Ph.D. in Toxicology from the University of Mainz.
University of Lisbon
Hugo Alexandre Ferreira holds degrees in medicine and in engineering physics and has a PhD in physics on the topic of bionanotechnology. He then worked in the medical device industry prior to returning to academia. Currently, he is an associate professor of biomedical engineering and biophysics at the University of Lisbon, teaching medical devices and digital health, and a PI in the fields of exponential digital technologies applied to health, including AI, XR, 3D printing, BCIs, wearables, and blockchain. Finally, he has co-founded and managed companies in the fields of IVD and imaging diagnostics, digital health, and sports and serves as a consultant and advisor in those fields.
Mitsubishi Gas Chemical
Mr. Hiroki Hasegawa is a researcher of research laboratory. He gained a Diploma in Science in 2013 and a Master Degree of Science in 2015 from Osaka University.Since April 2015 he has been working for Mitsubishi Gas Chemical Company, Inc. and in charge of macromolecular science, especially in composition development of thermosetting resin.Since 2018 he has joined a development team of multilayer plastic vial & syringe for biologics.
Director Business Development
Julien Storz is Director of Business Development within Aptar Pharma’s Consumer Healthcare (CHC) division. He holds a bachelor’s degree in Business Administration and has over 19 years of medical industry experience. Julien joined Aptar Pharma and the CHC Global Market Development team in 2019, where he is responsible for supporting business development efforts across numerous application fields in addition to driving CHC sustainability efforts.Join Julien Storz’ Learning Lab presentation to learn more and get introduced to the first in market metal-free recyclable nasal spray pump.
Director of Business Development
Juergen combines the medical, business and packaging world in his vita. With a bachelor’s degree in International Business Administration and an Executive MBA in Sales & Marketing Management, Jürgen spent the first 20 years of his professional life in different leadership roles in Amcor. Being also an advanced paramedic, he is passionate about the healthcare world and can add first-hand experience as a user to the sterile barrier world. Since 2018, Juergen is with Suedpack Medica and develops with his team the business of the future.
Commercial Director - Platforms and Products
Iain is a Commercial Director at Phillips-Medisize, where he is part of a global team developing industry leading solutions and platforms for drug delivery, digital medicine and connected health.He has worked for more than 20 years principally in lifesciences with an increasing focus on the use of devices and digital technologies to support drug deliveryHe has a degree and PhD in physics both from University College London and an MBE in Technology Management from the Open University. He lectures on Bioscience Enterprise at the University of Cambridge and is a regular conference speaker
VP Global Business Development
Keith Dodson is Vice President of Global Business Development and leads AST's global sales team. With an engineering background, Keith brings over 26 years total experience in the pharmaceutical and CDMO space having worked for multinational companies including 3M, Thermo Fisher, Eurofins and Catalent. Over his career, Keith has helped his customers around the world to identify, scope, and successfully implement capital equipment and technical services projects addressing critical business needs.
Springboard Pro Ltd.
Senior Consultant Mechanical Engineer
Kristien De Clercq is an experienced mechanical engineer with over nine years’ experience as a consultant in medical device development. She has led and delivered projects in a wide range of medical fields including specialist applications for ophthalmology and vascular conditions. Kristien draws on her background in aerodynamics and biomechanics, to bring creative ideas to her designs. As project leader at Springboard, she has a proven record of delivering technical excellence. She studied for a BSc in Aeronautical Engineering and a MSc in Experimental Aerodynamics at Delft University of Technology, followed by a postgraduate in Zoology at Cambridge University.
Novartis Pharma AG
Associate Director Oral Packaging & Delivery Systems
Lionel Jeannin is an Arts & Métiers ParisTech Engineer with a Master's degree in Business Administration from IAE Aix-Marseille Graduate School of Management. He earned certificates in Biochemistry and Biology, respectively, from Harvard University and the Massachusetts Institute of Technology. He has more than 22 years of experience in the Medical Device and Pharmaceutical industry.
He has worked as a Project and Development Team Manager in the Industrial Engineering, Ophthalmic surgery Medical Devices, Parenteral Nutrition and OTC/Rx Pharmaceutical development domains. He is currently heading the Oral Packaging and Delivery Systems Group in the Global Device and Packaging Development department of Novartis Pharma Technical Research and Development division.
BD Medical - Pharmaceutical Systems
Associate Director Program Management
Lionel is Associate Director at BD responsible for Program Management of New Product development and Sustaining Engineering activities. Lionel joined BD in 2005 and held roles of increasing responsibilities within the R&D and Project Management Office.
He has a deep experience in Drug Delivery Systems Design and Development from the Innovation stage to commercialisation in the field of Prefillable Syringes, Autoinjectors, Safety systems and Pens.
He developed, in particular, BD Physioject™ Autoinjector, which is listed in many patents. Before BD, Lionel worked in the Automotive Industry. He has a Master’s Degree in Engineering, specialising in plastic parts design and manufacturing.
MM Pharma Consulting
Senior CMC Consultant
Mario is an experienced pharmaceutical development professional with over 30 years of CMC contributions to pharmaceutical companies in international environment (Italy, Germany, Switzerland).
He has extensive experience in formulation and process development of Drug Products for clinical supplies, tech transfer and commercial manufacturing, including successful FDA approval of Mavenclad® for multiple sclerosis and Xadago® for Parkinson’s disease. Moreover, he contributed to the invention of a drug delivery system based on mesoporous silica for oral bioavailability enhancement (Parteck® SLC).
Currently he works as freelance CMC consultant, offering high added-value consultancy for Interim Management, CDMO/CMO outsourcing, IND/IMPD writing, EMA/FDA Scientific Advice meetings, due diligences and licensing.
Mario holds a MSc in Pharmacy and a MSc in Pharmaceutical Chemistry and Technology from University of Turin, Italy, and advanced Pharma Management education from London Business School, UK and Columbia Business School, NYC, USA.
Head of R&D
With a Bachelor’s degree in process engineering / mechanical engineering and Master's degree in plastics engineering, Michael is a technology lover and passionate about plastics! He has more than 25 years’ experience in packaging, and over 15 years in packaging for pharmaceuticals and GMP environment. Since early 2020 Michael works with SÜDPACK Medica as Head of R&D. He formerly worked with Etimex Primary Pack as Head of Development. Michael held various roles with BP in production and development, including application engineering, where he supported machine builders and customers during FAT & SAT, including troubleshooting. Michael was also Head of Sales with responsibility for CPP (Cast Polypropylene).
Business Development Manager
Started at Südpack Medica in September 2021. With a dual Bachelor’s degree in Industrial Design and Mechanical Engineering, Pieter brings over 16 years of experience in healthcare packaging with expertise in rigid barrier packaging. Focused on including patient safety till the point of care and improving patient outcomes.Formerly worked at Nelipak Healthcare Packaging with multiple international leadership roles in packaging design, development, and innovation management. Active member in Kilmer innovations in Packaging Sustainability committee, education committee, and the Sterile Barrier Association.
Head of Materials Development
Roberto Valenti is Head of Materials Development in Bormioli Pharma. After a first experience as technical for quality control of the raw materials, he has been in charge since January 1999 of the R&D activities aimed at the use and validation of innovative materials, such as sustainable plastics (recycled, bio-based) or barrier materials. Roberto Valenti is constantly updated on the latest developments through a consolidated network of partners and suppliers, supporting clients on their materials innovation projects.
Owen Mumford Pharmaceutical Services
Product Development Manager
Richard holds a bachelor’s engineering degree with honours in product design for manufacture. Richard started his career as an R&D engineer in 1995 designing inhalation drug delivery devices. He then went on to design combination/medicinal products at Bespak and later transitioned to Covidien (Medtronic) where he held roles in international upstream marketing and business development. He then moved on to various roles at Owen Mumford, Bespak and Novo Nordisk Engineering (NNE) in Denmark, before re-joining Owen Mumford in 2016. Richard is now dedicated to managing new injectable platform devices for Pharma and Biotech companies that meet market and user needs.
Senior Industrial Design Consultant
Tom is a senior industrial design consultant at Team Consulting, where he promotes effective design through clear and creative design decisions. He has over twelve years’ experience in design consulting and has been the lead industrial designer on several projects ranging from medical devices to consumer electronics. He has a degree in Industrial Design Technology from Brunel University London.
Director of Drug Delivery Device Development
Tom leads engineering and scientific teams developing new injection devices, pumps and inhalers. He has been the named inventor on dozens of patents throughout his 20 years’ experience in industry.He is a regular speaker at various international conferences on innovation and medical device development, and mentors Engineering and MBA students at the Cambridge University Engineering Department and the Judge Business School.He read Engineering at Cambridge University before becoming the Choate Fellow in Human Physiology and Pathology at Harvard University.
Schott Pharma AG & Co. KGaA
Head of Global Product Management Polymer Solutions
Tom Van Ginneken studied chemical engineering in Antwerp and added a MBA from the university of Sankt Gallen to his resume. After working in the chemical and pharmaceutical sector in Belgium for 3 years he joined SCHOTT in 2008.After different positions in the pharmaceutical product development department he became part of the product management team with focus on the SCHOTT TOPPAC® brand. In this role he works on the strategic orientation and innovation pipeline of the product group.
Principal Human Factors Engineer
I’ve been in the pharmaceutical industry for almost 9 years developing medical devices end to end, primarily in the combination product space. I’ve worked in all phases of development and excel at strategizing organizational development, platforms, and pipelines. Understanding stakeholder needs, the true context of use, and presenting unique solutions are some of my strong suits. With my broad range of product and patient experience, I bring a unique perspective.